Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.

Autor: Bal E; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Kumar R; Institute for Cancer Genetics, Columbia University, New York, NY, USA.; Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India., Hadigol M; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Holmes AB; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Hilton LK; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, British Columbia, Canada., Loh JW; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Dreval K; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada., Wong JCH; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, British Columbia, Canada., Vlasevska S; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Corinaldesi C; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Soni RK; Proteomics and Macromolecular Crystallography Shared Resource, Columbia University, New York, NY, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA., Basso K; Institute for Cancer Genetics, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Morin RD; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.; Genome Sciences Center, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Khiabanian H; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA., Pasqualucci L; Institute for Cancer Genetics, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu., Dalla-Favera R; Institute for Cancer Genetics, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Department of Genetics & Development, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Department of Microbiology & Immunology, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.
Jazyk: angličtina
Zdroj: Nature [Nature] 2022 Nov; Vol. 611 (7934), pp. E2.
DOI: 10.1038/s41586-022-05285-w
Databáze: MEDLINE